CD274 and neoplasm: In this study, we successfully developed a multifunctional biomimetic nanodelivery platform, PGFP+, offering an innovative strategy for tumor therapy by synergistically integrating targeted peptide‐mediated PD‐L1 protein degradation and photothermal immune regulation strategies.